Liposomal drug carrier systems in cancer chemotherapy: Current status and future prospects

被引：45

作者：

Gabizon, AA ^{[1
]}

机构：

[1] Shaare Zedek Med Ctr, Inst Oncol, Jerusalem, Israel

[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel

来源：

JOURNAL OF DRUG TARGETING | 2002年 / 10卷 / 07期

关键词：

D O I：

10.1080/1061186021000043061

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：535 / 538

页数：4

共 26 条

[11] Engineering liposomes for drug delivery: Progress and problems [J].

Gregoriadis, G .

TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) :527-537

[12] Phase I-II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer [J].

Harrington, KJ ;

Lewanski, CR ;

Northcote, AD ;

Whittaker, J ;

Wellbank, H ;

Vile, RG ;

Peters, AM ;

Stewart, JSW .

ANNALS OF ONCOLOGY, 2001, 12 (04) :493-496

[13]

Harrington KJ, 2001, CLIN CANCER RES, V7, P243

[14] Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma [J].

Harris, L ;

Batist, G ;

Belt, R ;

Rovira, D ;

Navari, R ;

Azarnia, N ;

Welles, K ;

Winer, E .

CANCER, 2002, 94 (01) :25-36

[15] Delivery of molecular and cellular medicine to solid tumors [J].

Jain, RK .

JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) :49-67

[16] Phase I and Pharmacologic study of liposomal lurtotecan, NX 211: Urinary excretion predicts hematologic toxicity [J].

Kehrer, DFS ;

Bos, AM ;

Verweij, J ;

Groen, HJ ;

Loos, WJ ;

Sparreboom, A ;

de Jonge, MJA ;

Hamilton, M ;

Cameron, T ;

de Vries, EGE .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1222-1231

[17] Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer [J].

Koukourakis, MI ;

Koukouraki, S ;

Giatromanolaki, A ;

Archimandritis, SC ;

Skarlatos, J ;

Beroukas, K ;

Bizakis, JG ;

Retalis, G ;

Karkavitsas, N ;

Helidonis, ES .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3512-3521

[18]

Martin F. J., 1997, ONCOLOGY S11, V11, P11

[19] STERICALLY STABILIZED LIPOSOMES - IMPROVEMENTS IN PHARMACOKINETICS AND ANTITUMOR THERAPEUTIC EFFICACY [J].

PAPAHADJOPOULOS, D ;

ALLEN, TM ;

GABIZON, A ;

MAYHEW, E ;

MATTHAY, K ;

HUANG, SK ;

LEE, KD ;

WOODLE, MC ;

LASIC, DD ;

REDEMANN, C ;

MARTIN, FJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11460-11464

[20] Pegylated liposomal doxorubicin (doxil):: Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2 [J].

Safra, T ;

Muggia, F ;

Jeffers, S ;

Tsao-Wei, DD ;

Groshen, S ;

Lyass, O ;

Henderson, R ;

Berry, G ;

Gabizon, A .

ANNALS OF ONCOLOGY, 2000, 11 (08) :1029-1033

← 1 2 3 →